Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer's Disease Platform

• मुख्य लेखकों: Tatiana Karelina (लेखक), Stepan Lerner (लेखक), Alexandr Stepanov (लेखक), Mark Meerson (लेखक), Oleg Demin (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Wiley, 2021-06-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract For many years, clinical research in Alzheimer's disease (AD) has focused on attempts to identify the most explicit biomarker, namely amyloid beta. Unfortunately, the numerous therapies that have been developed have failed in clinical practice. AD arises as a consequence of multiple fa...